+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Global Stem Cell Therapy Market 2024-2028

  • PDF Icon

    Report

  • 178 Pages
  • August 2024
  • Region: Global
  • TechNavio
  • ID: 4703294
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The stem cell therapy market is forecasted to grow by USD 16.67 billion during 2023-2028, accelerating at a CAGR of 18.69% during the forecast period. The report on the stem cell therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, increase in awareness of stem cell therapy, and rising regulatory approval for drug development.

The stem cell therapy market is segmented as below:

By Application

  • Cancer
  • Musculoskeletal disorder
  • Cardiovascular disease
  • Others

By Type

  • Allogeneic transplants
  • Autologous transplants

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rise in costs of stem cell transplantation as one of the prime reasons driving the stem cell therapy market growth during the next few years. Also, stem cell therapy being potential curative option for chronic diseases and development of ips cells will lead to sizable demand in the market.

The report on the stem cell therapy market covers the following areas:

  • Stem cell therapy market sizing
  • Stem cell therapy market forecast
  • Stem cell therapy market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading stem cell therapy market vendors that include Athersys Inc., Becton Dickinson and Co., Brainstorm Cell Therapeutics Inc., Bristol Myers Squibb Co., CRISPR Therapeutics AG, Cynata Therapeutics Ltd., Cytori Therapeutics Inc., FUJIFILM Corp., Gamida Cell Ltd., Johnson and Johnson Services Inc., Lonza Group Ltd., Mesoblast Ltd., Novartis AG, Pfizer Inc., Pluri Inc., ReNeuron Group plc, STEMCELL Technologies Inc., Takeda Pharmaceutical Co. Ltd., Thermo Fisher Scientific Inc., and Vericel Corp. Also, the stem cell therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Stem Cell Therapy Market 2018 - 2022
Historic Market Size - Data Table on Global Stem Cell Therapy Market 2018 - 2022 ($ million)
4.2 Application segment analysis 2018 - 2022
Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
6.1 Market segments
Chart on Application - Market share 2023-2028 (%)
Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
6.3 Cancer - Market size and forecast 2023-2028
Chart on Cancer - Market size and forecast 2023-2028 ($ million)
Data Table on Cancer - Market size and forecast 2023-2028 ($ million)
Chart on Cancer - Year-over-year growth 2023-2028 (%)
Data Table on Cancer - Year-over-year growth 2023-2028 (%)
6.4 Musculoskeletal disorder - Market size and forecast 2023-2028
Chart on Musculoskeletal disorder - Market size and forecast 2023-2028 ($ million)
Data Table on Musculoskeletal disorder - Market size and forecast 2023-2028 ($ million)
Chart on Musculoskeletal disorder - Year-over-year growth 2023-2028 (%)
Data Table on Musculoskeletal disorder - Year-over-year growth 2023-2028 (%)
6.5 Cardiovascular disease - Market size and forecast 2023-2028
Chart on Cardiovascular disease - Market size and forecast 2023-2028 ($ million)
Data Table on Cardiovascular disease - Market size and forecast 2023-2028 ($ million)
Chart on Cardiovascular disease - Year-over-year growth 2023-2028 (%)
Data Table on Cardiovascular disease - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by Type
7.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
7.3 Allogeneic transplants - Market size and forecast 2023-2028
Chart on Allogeneic transplants - Market size and forecast 2023-2028 ($ million)
Data Table on Allogeneic transplants - Market size and forecast 2023-2028 ($ million)
Chart on Allogeneic transplants - Year-over-year growth 2023-2028 (%)
Data Table on Allogeneic transplants - Year-over-year growth 2023-2028 (%)
7.4 Autologous transplants - Market size and forecast 2023-2028
Chart on Autologous transplants - Market size and forecast 2023-2028 ($ million)
Data Table on Autologous transplants - Market size and forecast 2023-2028 ($ million)
Chart on Autologous transplants - Year-over-year growth 2023-2028 (%)
Data Table on Autologous transplants - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Athersys Inc.
Athersys Inc. - Overview
Athersys Inc. - Product / Service
Athersys Inc. - Key offerings
12.4 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.5 CRISPR Therapeutics AG
CRISPR Therapeutics AG - Overview
CRISPR Therapeutics AG - Product / Service
CRISPR Therapeutics AG - Key offerings
12.6 Cynata Therapeutics Ltd.
Cynata Therapeutics Ltd. - Overview
Cynata Therapeutics Ltd. - Product / Service
Cynata Therapeutics Ltd. - Key offerings
12.7 FUJIFILM Corp.
FUJIFILM Corp. - Overview
FUJIFILM Corp. - Business segments
FUJIFILM Corp. - Key news
FUJIFILM Corp. - Key offerings
FUJIFILM Corp. - Segment focus
12.8 Gamida Cell Ltd.
Gamida Cell Ltd. - Overview
Gamida Cell Ltd. - Product / Service
Gamida Cell Ltd. - Key offerings
12.9 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.10 Lonza Group Ltd.
Lonza Group Ltd. - Overview
Lonza Group Ltd. - Business segments
Lonza Group Ltd. - Key news
Lonza Group Ltd. - Key offerings
Lonza Group Ltd. - Segment focus
12.11 Mesoblast Ltd.
Mesoblast Ltd. - Overview
Mesoblast Ltd. - Product / Service
Mesoblast Ltd. - Key offerings
12.12 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.13 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.14 Pluri Inc.
Pluri Inc. - Overview
Pluri Inc. - Product / Service
Pluri Inc. - Key offerings
12.15 ReNeuron Group plc
ReNeuron Group plc - Overview
ReNeuron Group plc - Product / Service
ReNeuron Group plc - Key offerings
12.16 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings
12.17 Vericel Corp.
Vericel Corp. - Overview
Vericel Corp. - Product / Service
Vericel Corp. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global Stem Cell Therapy Market 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on Application - Market share 2023-2028 (%)
Exhibits 33: Data Table on Application - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by Application
Exhibits 35: Data Table on Comparison by Application
Exhibits 36: Chart on Cancer - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Data Table on Cancer - Market size and forecast 2023-2028 ($ million)
Exhibits 38: Chart on Cancer - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on Cancer - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on Musculoskeletal disorder - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Data Table on Musculoskeletal disorder - Market size and forecast 2023-2028 ($ million)
Exhibits 42: Chart on Musculoskeletal disorder - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on Musculoskeletal disorder - Year-over-year growth 2023-2028 (%)
Exhibits 44: Chart on Cardiovascular disease - Market size and forecast 2023-2028 ($ million)
Exhibits 45: Data Table on Cardiovascular disease - Market size and forecast 2023-2028 ($ million)
Exhibits 46: Chart on Cardiovascular disease - Year-over-year growth 2023-2028 (%)
Exhibits 47: Data Table on Cardiovascular disease - Year-over-year growth 2023-2028 (%)
Exhibits 48: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 49: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 52: Market opportunity by Application ($ million)
Exhibits 53: Data Table on Market opportunity by Application ($ million)
Exhibits 54: Chart on Type - Market share 2023-2028 (%)
Exhibits 55: Data Table on Type - Market share 2023-2028 (%)
Exhibits 56: Chart on Comparison by Type
Exhibits 57: Data Table on Comparison by Type
Exhibits 58: Chart on Allogeneic transplants - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Data Table on Allogeneic transplants - Market size and forecast 2023-2028 ($ million)
Exhibits 60: Chart on Allogeneic transplants - Year-over-year growth 2023-2028 (%)
Exhibits 61: Data Table on Allogeneic transplants - Year-over-year growth 2023-2028 (%)
Exhibits 62: Chart on Autologous transplants - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Data Table on Autologous transplants - Market size and forecast 2023-2028 ($ million)
Exhibits 64: Chart on Autologous transplants - Year-over-year growth 2023-2028 (%)
Exhibits 65: Data Table on Autologous transplants - Year-over-year growth 2023-2028 (%)
Exhibits 66: Market opportunity by Type ($ million)
Exhibits 67: Data Table on Market opportunity by Type ($ million)
Exhibits 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 69: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 70: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 71: Chart on Geographic comparison
Exhibits 72: Data Table on Geographic comparison
Exhibits 73: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 102: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 103: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 105: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 106: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 107: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 108: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 109: Market opportunity By Geographical Landscape ($ million)
Exhibits 110: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 111: Impact of drivers and challenges in 2023 and 2028
Exhibits 112: Overview on criticality of inputs and factors of differentiation
Exhibits 113: Overview on factors of disruption
Exhibits 114: Impact of key risks on business
Exhibits 115: Companies covered
Exhibits 116: Matrix on companies position and classification
Exhibits 117: Athersys Inc. - Overview
Exhibits 118: Athersys Inc. - Product / Service
Exhibits 119: Athersys Inc. - Key offerings
Exhibits 120: Bristol Myers Squibb Co. - Overview
Exhibits 121: Bristol Myers Squibb Co. - Product / Service
Exhibits 122: Bristol Myers Squibb Co. - Key news
Exhibits 123: Bristol Myers Squibb Co. - Key offerings
Exhibits 124: CRISPR Therapeutics AG - Overview
Exhibits 125: CRISPR Therapeutics AG - Product / Service
Exhibits 126: CRISPR Therapeutics AG - Key offerings
Exhibits 127: Cynata Therapeutics Ltd. - Overview
Exhibits 128: Cynata Therapeutics Ltd. - Product / Service
Exhibits 129: Cynata Therapeutics Ltd. - Key offerings
Exhibits 130: FUJIFILM Corp. - Overview
Exhibits 131: FUJIFILM Corp. - Business segments
Exhibits 132: FUJIFILM Corp. - Key news
Exhibits 133: FUJIFILM Corp. - Key offerings
Exhibits 134: FUJIFILM Corp. - Segment focus
Exhibits 135: Gamida Cell Ltd. - Overview
Exhibits 136: Gamida Cell Ltd. - Product / Service
Exhibits 137: Gamida Cell Ltd. - Key offerings
Exhibits 138: Johnson and Johnson Services Inc. - Overview
Exhibits 139: Johnson and Johnson Services Inc. - Business segments
Exhibits 140: Johnson and Johnson Services Inc. - Key news
Exhibits 141: Johnson and Johnson Services Inc. - Key offerings
Exhibits 142: Johnson and Johnson Services Inc. - Segment focus
Exhibits 143: Lonza Group Ltd. - Overview
Exhibits 144: Lonza Group Ltd. - Business segments
Exhibits 145: Lonza Group Ltd. - Key news
Exhibits 146: Lonza Group Ltd. - Key offerings
Exhibits 147: Lonza Group Ltd. - Segment focus
Exhibits 148: Mesoblast Ltd. - Overview
Exhibits 149: Mesoblast Ltd. - Product / Service
Exhibits 150: Mesoblast Ltd. - Key offerings
Exhibits 151: Novartis AG - Overview
Exhibits 152: Novartis AG - Business segments
Exhibits 153: Novartis AG - Key news
Exhibits 154: Novartis AG - Key offerings
Exhibits 155: Novartis AG - Segment focus
Exhibits 156: Pfizer Inc. - Overview
Exhibits 157: Pfizer Inc. - Product / Service
Exhibits 158: Pfizer Inc. - Key news
Exhibits 159: Pfizer Inc. - Key offerings
Exhibits 160: Pluri Inc. - Overview
Exhibits 161: Pluri Inc. - Product / Service
Exhibits 162: Pluri Inc. - Key offerings
Exhibits 163: ReNeuron Group plc - Overview
Exhibits 164: ReNeuron Group plc - Product / Service
Exhibits 165: ReNeuron Group plc - Key offerings
Exhibits 166: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 167: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits 168: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 169: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 170: Vericel Corp. - Overview
Exhibits 171: Vericel Corp. - Product / Service
Exhibits 172: Vericel Corp. - Key offerings
Exhibits 173: Inclusions checklist
Exhibits 174: Exclusions checklist
Exhibits 175: Currency conversion rates for US$
Exhibits 176: Research methodology
Exhibits 177: Information sources
Exhibits 178: Data validation
Exhibits 179: Validation techniques employed for market sizing
Exhibits 180: Data synthesis
Exhibits 181: 360 degree market analysis
Exhibits 182: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global stem cell therapy market: Athersys Inc., Becton Dickinson and Co., Brainstorm Cell Therapeutics Inc., Bristol Myers Squibb Co., CRISPR Therapeutics AG, Cynata Therapeutics Ltd., Cytori Therapeutics Inc., FUJIFILM Corp., Gamida Cell Ltd., Johnson and Johnson Services Inc., Lonza Group Ltd., Mesoblast Ltd., Novartis AG, Pfizer Inc., Pluri Inc., ReNeuron Group plc, STEMCELL Technologies Inc., Takeda Pharmaceutical Co. Ltd., Thermo Fisher Scientific Inc., and Vericel Corp..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rise in costs of stem cell transplantation."

According to the report, one of the major drivers for this market is the increasing prevalence of chronic diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Athersys Inc.
  • Becton Dickinson and Co.
  • Brainstorm Cell Therapeutics Inc.
  • Bristol Myers Squibb Co.
  • CRISPR Therapeutics AG
  • Cynata Therapeutics Ltd.
  • Cytori Therapeutics Inc.
  • FUJIFILM Corp.
  • Gamida Cell Ltd.
  • Johnson and Johnson Services Inc.
  • Lonza Group Ltd.
  • Mesoblast Ltd.
  • Novartis AG
  • Pfizer Inc.
  • Pluri Inc.
  • ReNeuron Group plc
  • STEMCELL Technologies Inc.
  • Takeda Pharmaceutical Co. Ltd.
  • Thermo Fisher Scientific Inc.
  • Vericel Corp.